Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Parker Faxon, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Faxon DP. Tailored Antiplatelet Therapy in Patients Undergoing PCI: Is Rapid Bedside Genetic Testing the Answer? JACC Basic Transl Sci. 2020 May; 5(5):429-431. PMID: 32479567.
    Citations:    
  2. Faxon DP. Absorb Bioresorbable Scaffolds-Out of the Woods After 3 Years? JAMA Cardiol. 2019 12 01; 4(12):1192-1193. PMID: 31561253.
    Citations:    
  3. Tsao AL, Faxon DP. Fractional Flow Reserve: Does Sex Matter? JACC Cardiovasc Interv. 2019 10 28; 12(20):2047-2049. PMID: 31648765.
    Citations:    
  4. Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendón J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum Á, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodés-Cabau J, Stankovic G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2019 10 10; 381(15):1411-1421. PMID: 31475795.
    Citations:    
  5. Capodanno D, Huber K, Mehran R, Lip GYH, Faxon DP, Granger CB, Vranckx P, Lopes RD, Montalescot G, Cannon CP, Ten Berg J, Gersh BJ, Bhatt DL, Angiolillo DJ. Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 07 09; 74(1):83-99. PMID: 31272556.
    Citations:    
  6. Faxon D, Berry NC. Best Revascularization Strategies in Patients With CKD and DM: Still Uncertain. J Am Coll Cardiol. 2019 02 05; 73(4):412-414. PMID: 30704572.
    Citations:    Fields:    
  7. Bergmark BA, Faxon DP. Transient ST-segment myocardial infarction: a new category of high risk acute coronary syndrome? Eur Heart J. 2019 01 14; 40(3):292-294. PMID: 30445457.
    Citations:    Fields:    
  8. Mohl W, Milasinovic D, Faxon DP. Amending a dogma. EuroIntervention. 2018 Dec 20; 14(12):e1258-e1261. PMID: 30566082.
    Citations:    Fields:    
  9. Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. Circulation. 2018 07 31; 138(5):527-536. PMID: 30571525.
    Citations:    Fields:    
  10. Faxon DP, Berry NC. Post-Percutaneous Coronary Intervention Discharge Against Medical Advice: Infrequent But Deadly. JACC Cardiovasc Interv. 2018 07 23; 11(14):1365-1367. PMID: 30025730.
    Citations:    Fields:    
  11. Dempsey J, Gillis C, Sibicky S, Matta L, MacRae C, Kirshenbaum J, Faxon D, Churchill W. Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population. Am J Health Syst Pharm. 2018 Sep 01; 75(17 Supplement 3):S63-S71. PMID: 29976830.
    Citations:    Fields:    
  12. Faxon DP, Leopold JA, Abbott JD, McElhinney DB, Williams DO. Circulation: Cardiovascular Interventions: The First 10 Years. Circ Cardiovasc Interv. 2018 06; 11(6):e006901. PMID: 29895606.
    Citations:    Fields:    
  13. Bravo CA, Hirji SA, Bhatt DL, Gluud C, Faxon DP, Ohman EM, Kaneko T, Engstrøm T, Høfsten DE, Brennan JM. Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease. Heart. 2018 07; 104(14):1144-1147. PMID: 29439169.
    Citations:    Fields:    Translation:Humans
  14. Vaduganathan M, Qamar A, Badreldin HA, Faxon DP, Bhatt DL. Reply: Cangrelor or Abciximab as First Choice in Cardiogenic Shock. JACC Cardiovasc Interv. 2017 12 11; 10(23):2468-2469. PMID: 29217013.
    Citations:    Fields:    Translation:Humans
  15. Bossard M, Granger CB, Tanguay JF, Montalescot G, Faxon DP, Jolly SS, Widimsky P, Niemela K, Steg PG, Natarajan MK, Gao P, Fox KAA, Yusuf S, Mehta SR. Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2017 Nov 03; 6(11). PMID: 29101117.
    Citations: 2     Fields:    Translation:Humans
  16. Anderson HV, Faxon DP. Balanced Adoption of Radial Artery Access for Primary Percutaneous Coronary Intervention. JAMA Cardiol. 2017 10 01; 2(10):1059-1060. PMID: 28813571.
    Citations:    Fields:    
  17. Vaduganathan M, Qamar A, Badreldin HA, Faxon DP, Bhatt DL. Cangrelor Use in Cardiogenic Shock: A Single-Center Real-World Experience. JACC Cardiovasc Interv. 2017 08 28; 10(16):1712-1714. PMID: 28838482.
    Citations: 1     Fields:    
  18. Mangione FM, Jatene T, Badr Eslam R, Bergmark BA, Gallagher JR, Shah PB, Mauri L, Leopold JA, Sobieszczyk PS, Faxon DP, Croce KJ, Bhatt DL, Devlin PM. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis. Am J Cardiol. 2017 Aug 01; 120(3):369-373. PMID: 28583681.
    Citations:    Fields:    Translation:Humans
  19. Bravo CA, Hirji SA, Bhatt DL, Kataria R, Faxon DP, Ohman EM, Anderson KL, Sidi AI, Sketch MH, Zarich SW, Osho AA, Gluud C, Kelbæk H, Engstrøm T, Høfsten DE, Brennan JM. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease. Cochrane Database Syst Rev. 2017 May 03; 5:CD011986. PMID: 28470696.
    Citations: 3     Fields:    Translation:Humans
  20. Golwala HB, Kalra A, Faxon DP. Establishing A Contemporary Training Curriculum for the Next Generation of Interventional Cardiology Fellows. Circ Cardiovasc Interv. 2017 04; 10(4). PMID: 28385700.
    Citations:    Fields:    
  21. Vaduganathan M, Qamar A, Singh A, Venkateswaran RV, Szumita PM, Croce KJ, Mauri L, Leopold JA, Shah PB, Sobieszczyk P, Faxon DP, Bhatt DL. Cangrelor Use Since FDA Approval: A Single-Center, Real-World Experience at a Tertiary Care Hospital. J Am Coll Cardiol. 2017 01 31; 69(4):463-464. PMID: 27914699.
    Citations:    Fields:    
  22. Wimmer NJ, Dufour AB, Cho K, Gagnon DR, Quach L, Ly S, Do JM, Ostrowski S, Michael Gaziano J, Faxon DP, Kinlay S. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):1176-1184. PMID: 27860195.
    Citations:    Fields: